PHARMACY

Bayer, Onyx to enroll patients for thyroid cancer clinical trial

BY Alaric DeArment

BERLIN German drug maker Bayer HealthCare and partner Onyx Pharmaceuticals have started enrolling patients for a late-stage clinical trial of a drug in patients with thyroid cancer.

Bayer announced Friday the beginning of a Phase 3 trial of Nexavar (sorafenib) in patients with locally advanced or metastatic thyroid cancer that refracts radioactive iodine. The companies started the trial based on results from a Phase 2 trial of the drug in patients with advanced thyroid cancer.

“Patients with thyroid cancer, particularly those who failed to respond to surgical or radiotherapies have limited treatment options to help them manage their disease,” Bayer HealthCare VP clinical development Dimitris Voliotis said in a statement. “Recognizing this unmet need, we are evaluating Nexavar in this special patient population.”

The companies will enroll 400 patients in multiple countries for the placebo-controlled trial.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

FDA approves Diuril generic

BY Alaric DeArment

SCHAUMBURG, Ill. The Food and Drug Administration has approved the first generic version of an injected drug for hypertension.

APP Pharmaceuticals announced the approval of chlorothiazide sodium, which it plans to launch in fourth quarter 2009.

 

The drug is a generic version of Lundbeck Pharmaceuticals’ Diuril, a diuretic used for treating hypertension and fluid retention in patients with congestive heart failure, cirrhosis of the liver, kidney disorders and edema.

 

Diuril had sales of $51 million in 2008, according to IMS Health data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

CVS launches interactive Web and mobile features online

BY Antoinette Alexander

WOONSOCKET, R.I. CVS Caremark is providing customers with more tools to help them manage prescriptions, access health information and save money through new interactive Web and mobile features at CVS.com.

The new CVS.com Mobile (m.cvs.com) provides customers with an on-the-go pharmacy resource to refill, transfer and manage prescriptions. They can also find store locations and take advantage of such features as Savings Central and Virtual Gift Card. 

“The new CVS.com Mobile site is a helpful resource for customers who rely on real-time access to their medication history, drug information or simply need help with driving directions or a phone number to a nearby CVS/pharmacy or MinuteClinic,” stated Helena Foulkes, CMO of CVS Caremark. “Additionally, Savings Central provides users with a one-stop online destination for information on health care savings, deals and discounts. These new features, along with the addition of Virtual Gift Cards, are examples of how we are continuing to enhance the customer experience, both in-store and online.” 

By visiting CVS.com Mobile, patients can access the Drug Information Center, which allows rapid access to details about medication management, including instructions for use, dosing information, side effects and relevant safety warnings. 

Meanwhile, the new Savings Central combines information about healthcare savings with other deals and discounts in one location. By clicking on the “Savings Central” tab, budget-conscious customers can find ways to save money through coupons and special promotions. There are tabbed pages detailing information on such topics as pharmacy savings, circulars, in-store coupons, and online sales and specials.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?